Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CRS Mannheim is a leading German CRO specializing in early-phase clinical research. It has conducted over 500 trials across cardiometabolic, CNS, dermatology, ARDS, pain management and more. The site is known for its expertise in first-in-human studies and complex PK/PD designs. Recent research includes innovative therapies for diabetes (orforglipron), obesity (AZD5004), chronic pain associated with diabetic neuropathy, hepatic impairment studies with leniolisib, and dermatological indications like psoriasis and hidradenitis suppurativa.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CRS Clinical Research Services Mannheim.